Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Sanofi India Limited (SANOFI.BO)

6,278.45
-292.05
(-4.44%)
At close: 3:42:40 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
20,132,000
20,132,000
19,961,000
27,272,000
29,233,000
Cost of Revenue
9,793,000
9,793,000
9,535,000
12,439,000
13,638,000
Gross Profit
10,339,000
10,339,000
10,426,000
14,833,000
15,595,000
Operating Expense
5,798,000
5,798,000
5,914,000
8,177,000
8,637,000
Operating Income
4,541,000
4,541,000
4,512,000
6,656,000
6,958,000
Net Non Operating Interest Income Expense
-15,000
-15,000
-17,000
572,000
613,000
Pretax Income
4,314,000
4,314,000
5,285,000
8,643,000
12,576,000
Tax Provision
1,177,000
1,177,000
1,639,000
2,437,000
3,132,000
Net Income Common Stockholders
4,133,000
4,133,000
6,029,000
6,206,000
9,444,000
Diluted NI Available to Com Stockholders
4,133,000
4,133,000
6,029,000
6,206,000
9,444,000
Basic EPS
199.60
179.46
261.78
269.47
410.06
Diluted EPS
199.60
179.46
261.78
269.47
410.06
Basic Average Shares
23,030.93
23,030.20
23,030.79
23,030.62
23,030.62
Diluted Average Shares
23,030.93
23,030.20
23,030.79
23,030.62
23,030.62
Rent Expense Supplemental
--
--
11,000
17,000
36,000
Total Expenses
15,591,000
15,591,000
15,449,000
20,616,000
22,275,000
Net Income from Continuing & Discontinued Operation
4,133,000
4,133,000
6,029,000
6,206,000
9,444,000
Normalized Income
3,411,142.10
3,411,142.10
3,523,201.89
5,280,449.38
5,720,769.08
Interest Income
--
--
475,000
589,000
631,000
Interest Expense
15,000
15,000
17,000
17,000
18,000
Net Interest Income
-15,000
-15,000
-17,000
572,000
613,000
EBIT
4,329,000
4,329,000
5,302,000
8,660,000
12,594,000
EBITDA
4,711,000
4,711,000
5,698,000
9,079,000
13,261,000
Reconciled Cost of Revenue
9,793,000
9,793,000
9,535,000
12,439,000
13,638,000
Reconciled Depreciation
382,000
382,000
396,000
419,000
667,000
Net Income from Continuing Operation Net Minority Interest
3,137,000
3,137,000
3,646,000
6,206,000
9,444,000
Total Unusual Items Excluding Goodwill
-377,000
-377,000
178,000
1,289,000
4,958,000
Total Unusual Items
-377,000
-377,000
178,000
1,289,000
4,958,000
Normalized EBITDA
5,088,000
5,088,000
5,520,000
7,790,000
8,303,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-102,857.90
-102,857.90
55,201.89
363,449.38
1,234,769.08
12/31/2021 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0O59.IL Sanofi
92.53
-1.01%
 
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,804.05
-3.86%
 
1BAYN.MI Bayer Aktiengesellschaft
23.00
+2.04%
 
BAYRY Bayer Aktiengesellschaft
6.62
+2.48%
 
SNY Sanofi
52.32
-2.28%
 
SAN.PA Sanofi
92.36
-1.06%
 
AZN.L AstraZeneca PLC
10,400.00
-0.42%
 
NVS Novartis AG
112.14
+0.87%
 
ROG.SW Roche Holding AG
261.90
-0.15%
 
GSK GSK plc
37.43
-0.19%